Drug search by name

Albendazole Tablets and Myelosuppression

Result of checking the interaction of drug Albendazole Tablets and disease Myelosuppression for safety when used together.

Check result:

Albendazole Tablets <> Myelosuppression

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Reversible leukopenia has been reported during albendazole therapy. Rarely, granulocytopenia or pancytopenia have resulted in death. Therapy with albendazole should be administered cautiously in patients with predisposition to myelosuppression. Clinical monitoring of hematopoietic function prior to each cycle of albendazole and every two weeks during therapy is recommended. Albendazole can be continued with a modest, non- progressive decrease in leukocyte count and absolute neutrophil count.

References:

"Product Information. Albenza (albendazole)." SmithKline Beecham, Philadelphia, PA.
Fernandez FJ, Rodriguezvidigal FF, Ledesma V, Cabanillas Y, Vagace JM "Aplastic anemia during treatment with albendazole." Am J Hematol 53 (1996): 53-4

Albendazole Tablets

Generic Name: albendazole

Brand Name: Albenza

Synonyms: Albendazole

What is Albendazole Tablets?